Ophthalmology · Plantation, FL
NPI
1457353054
Since 2005
Specialty
Ophthalmology
Code 207W00000X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
850 S. Pine Island Rd., Ste. A100
Plantation, FL, 33351
Phone (954) 741-5555
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.4M
76,007 services
Medicare patients, 2024
402
Average age 77
Drug cost, 2024
$69K
279 prescriptions
Company payments, 2025
$575
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tirso M Lara was code J2403 (chloroprocaine hcl ophthalmic, 3% gel, 1 mg), 49,600 times for 50 patients. In total Tirso M Lara billed 76,007 services in 42 codes, and Medicare paid $1.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2403 Chloroprocaine hcl ophthalmic, 3% gel, 1 mg | Office | 49,600 | 50 | $0.49 | $24K |
| J2777 Injection, faricimab-svoa, 0.1 mg | Office | 18,720 | 81 | $27.45 | $514K |
| Q5128 Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | Office | 1,521 | 73 | $189.38 | $288K |
| J2781 Injection, pegcetacoplan, intravitreal, 1 mg | Office | 1,230 | 17 | $117.14 | $144K |
| 92134 Computerized Ophthalmic Imaging | Office | 1,004 | 376 | $29.76 | $30K |
| 67028 Intravitreal Injection | Office | 852 | 139 | $89.42 | $76K |
| 92202 Ophthalmological E&M | Office | 590 | 166 | $11.58 | $6,835 |
| 92250 Angiography | Office | 517 | 335 | $27.66 | $14K |
| 99214 Office E&M - Established | Office | 436 | 193 | $94.04 | $41K |
| 99213 Office E&M - Established | Office | 249 | 193 | $61.82 | $15K |
| 92014 Ophthalmological E&M | Office | 128 | 117 | $100.69 | $13K |
| 92235 Angiography | Office | 118 | 106 | $116.97 | $14K |
| 92273 Test - Miscellaneous | Office | 88 | 85 | $94.45 | $8,312 |
| 92242 Angiography | Office | 81 | 67 | $220.06 | $18K |
| J0178 Injection, aflibercept, 1 mg | Office | 64 | 12 | $663.34 | $42K |
By year: 2022 $1.3M for 10,545 services; 2023 $1.5M for 35,963 services; 2024 $1.4M for 76,007 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tirso M Lara prescribed most often to Medicare patients was Prednisolone Acetate, with 70 prescriptions and refills. In total Tirso M Lara wrote 279 Medicare prescriptions that cost $69K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisolone Acetate Generic | 70 | 91 | 46 | $2,364 |
| Latanoprost Generic | 32 | 62 | 19 | $265 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 29 | 48 | 11 | $670 |
| Moxifloxacin Moxifloxacin Hcl | 20 | 20 | 18 | $611 |
| Cimerli Ranibizumab-Eqrn | 14 | 21 | Under 11 | $16K |
| Prolensa Bromfenac Sodium | 12 | 13 | Under 11 | $5,618 |
| Timolol Maleate Generic | 12 | 21 | Under 11 | $62.79 |
| Alphagan P Brimonidine Tartrate | 11 | 21 | Under 11 | $3,530 |
Brand drugs: 173 claims; generic drugs: 106 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tirso M Lara $575 ($575 in general payments such as food, travel and fees) from 9 companies. The largest payer was US Oncology Corporate, Inc. with $107.
| Company | Payments | Amount |
|---|---|---|
| US Oncology Corporate, Inc. | 1 | $107 |
| Genentech USA, Inc. ROG.SW | 4 | $106 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $105 |
| Astellas Pharma US Inc 4503.T | 3 | $95.7 |
| Abbvie Inc. ABBV | 2 | $58.71 |
| Apellis Pharmaceuticals, Inc. APLS | 1 | $31.66 |
| Harrow Eye, LLC | 1 | $25.48 |
| Sandoz Inc. SDZ.SW | 1 | $24.81 |
| Notal Vision, Inc. | 1 | $19.89 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.